H CYTE Inc (QB) (HCYT)
USOTC
H-CYTE is a hybrid-biopharmaceutical company dedicated to developing and delivering a novel portfolio of new diagnostics, therapeutics, and medical devices from concept to commercialization. H-CYTE is a hybrid-biopharmaceutical company dedicated to developing and delivering a novel portfolio of new diagnostics, therapeutics, and medical devices from concept to commercialization.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | -0.005 | -0.5 | 1 | 1.1 | 0.5002 | 1938 | 0.999822 | CS |
156 | 0.96 | 2742.85714286 | 0.035 | 7 | 0.01 | 146636 | 0.05977761 | CS |
260 | 0.495 | 99 | 0.5 | 7 | 0.006 | 91729 | 0.07155495 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.